Trial · NCT01369355
Adverse events3,192
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,192
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Ustekinumab Induction Responders(USTIRsp) Placebo Maintenance | 0 | 133 | |
| other | Anaemia | Blood and lymphatic system disorders | UST -I-Rsp -PBO Maintenance -UST-90mg SC Q8W- Maintenance | 0 | 51 | |
| other | Anaemia | Blood and lymphatic system disorders | UST-I-Rsp-UST 90 mg SC Every 12 Weeks (Q12W) Maintenance | 5 | 132 | |
| other | Anaemia | Blood and lymphatic system disorders | UST-I-Rsp-UST 90 mg SC Q12W/Q8W Maintenance | 1 | 29 | |
| other | Anaemia | Blood and lymphatic system disorders | UST-I-Rsp-UST 90 mg SC Q8W Maintenance | 3 | 131 | |
| other | Anaemia | Blood and lymphatic system disorders | UST IV-I-Rsp-UST-90mg Maintenance-UST-90mg SC Q8W Maintenance | 0 | 29 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo (PBO)-I-Rsp PBO Maintenance | 5 | 123 | |
| other | Anaemia | Blood and lymphatic system disorders | PBO-I-nonRsp- UST-130mg Intravenous/90mg SC Q12W Maintenance | 6 | 285 | |
| other | Anaemia | Blood and lymphatic system disorders | UST IV-I-nonRsp - UST-90 mg SC Q8W Maintenance | 11 | 476 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo Long Term Extension (LTE) | 2 | 151 | |
| other | Anaemia | Blood and lymphatic system disorders | UST 90 mg SC Q12W LTE | 15 | 213 | |
| other | Anaemia | Blood and lymphatic system disorders | UST 90 mg SC Q8W LTE | 17 | 354 | |
| other | Abdominal Pain | Gastrointestinal disorders | Ustekinumab Induction Responders(USTIRsp) Placebo Maintenance | 17 | 133 | |
| other | Abdominal Pain | Gastrointestinal disorders | UST -I-Rsp -PBO Maintenance -UST-90mg SC Q8W- Maintenance | 3 | 51 | |
| other | Abdominal Pain | Gastrointestinal disorders | UST-I-Rsp-UST 90 mg SC Every 12 Weeks (Q12W) Maintenance | 12 | 132 | |
| other | Abdominal Pain | Gastrointestinal disorders | UST-I-Rsp-UST 90 mg SC Q12W/Q8W Maintenance | 5 | 29 | |
| other | Abdominal Pain | Gastrointestinal disorders | UST-I-Rsp-UST 90 mg SC Q8W Maintenance | 11 | 131 | |
| other | Abdominal Pain | Gastrointestinal disorders | UST IV-I-Rsp-UST-90mg Maintenance-UST-90mg SC Q8W Maintenance | 1 | 29 | |
| other | Abdominal Pain | Gastrointestinal disorders | Placebo (PBO)-I-Rsp PBO Maintenance | 15 | 123 | |
| other | Abdominal Pain | Gastrointestinal disorders | PBO-I-nonRsp- UST-130mg Intravenous/90mg SC Q12W Maintenance | 23 | 285 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01369355/events